World Health Organization – Page 24 – Communicable Diseases Research

Moxibustion for anorexia in COVID-19 A protocol for systematic review and meta-analysis

COVID-19에서 식욕 부진에 대한 moxibustion 체계적인 검토 및 메타 분석을위한 프로토콜

3800

Published on 2022-02-252022-08-31
Journal: Medicine [Category] COVID-19, COVID19(2023년), MERS, meta-analysis, SARS,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anorexia assessment tool carried caused China Chinese Cochrane Library controlled trials corona virus disease 2019 coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 digestive Efficacy and safety evaluate evaluated Evidence exclusion criteria Health Organization Inclusion inclusion and exclusion criteria Infrastructure international public health journal language Liver injury Markov chain Markov chain Monte Carlo method Meta-analysis Monte Carlo method moxibustion network Network meta-analysis outbreak patients with COVID-19 performed protocol Randomized controlled trial Randomized controlled trials registration number reported respiratory respiratory symptoms risk SARS-CoV-2 screened severe acute respiratory syndrome Coronavirus Spread Stata Symptom systematic review the disease therapy Traditional Chinese medicine treat Treatment Trial Registration Number typical respiratory symptom typical respiratory symptoms used to evaluate World Health Organization
[DOI] 10.1097/MD.0000000000028894 PMC 바로가기 [Article Type] 3800

Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment

Review

Published on 2022-02-252022-10-30
Journal: Nanomaterials [Category] COVID-19,

Sentiment analysis and topic modeling for COVID-19 vaccine discussions

Article

Published on 2022-02-252022-10-29
Journal: World Wide Web [Category] COVID-19,

Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models

Remdesivir 대사 산물 GS-441524, 마우스 모델에서 SARS-CoV-2 감염을 효과적으로 억제

Article

Published on 2022-02-242022-09-11
Journal: Journal of medicinal chemistry [Category] MERS, 진단, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 approved cell lines challenge conducted coronavirus coronavirus disease Coronavirus disease 2019 CoV COVID-19 Diseases drug drug candidate Effectiveness food global pandemic GS-441524 Health Organization Hepatitis infected organs inhibit manuscript mice Model mouse murine hepatitis virus notable nucleoside organ outbreak parent nucleoside question reducing Remdesivir Replication replication of SARS-CoV-2 respiratory SARS-CoV-2 severe acute respiratory syndrome Coronavirus Solidarity trial Spread Support the United State Toxicity treating Treatment United States United States Food and Drug Administration Vero E6 Viral viral titer viral titers World Health Organization
[DOI] 10.1021/acs.jmedchem.0c01929 PMC 바로가기 [Article Type] Article

Cascaded 3D UNet architecture for segmenting the COVID-19 infection from lung CT volume

Article

Published on 2022-02-232022-10-04
Journal: Scientific Reports [Category] 치료기술,

Association of stigma with mental health and quality of life among Indonesian COVID-19 survivors

Research Article

Published on 2022-02-232022-10-28
Journal: PLoS ONE [Category] COVID-19, COVID19(2023년), MERS, SARS,

Association between living in municipalities with high crowding conditions and poverty and mortality from COVID-19 in Mexico

Research Article

Published on 2022-02-222022-10-28
Journal: PLoS ONE [Category] COVID-19, COVID19(2023년), MERS, SARS,

[키워드] 95% CI acute respiratory syndrome Affect age Analysis association Characteristics collected condition coronavirus COVID-19 COVID-19 pandemic death develop disease elevated examined food insecurity frailty Health Health Service Healthcare systems higher risk illiteracy implication increased risk increased the risk individual information less Ministry of Health Mortality objective Occurrence outcome pandemic Patient platform Policy populations positive random effect reduce regression models Result risk SARS-CoV-2 subject System tested the patient viral respiratory World Health Organization
[DOI] 10.1371/journal.pone.0264137 PMC 바로가기 [Article Type] Research Article

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

캐나다에서 COVID-19로 병원에 입원한 환자의 치료를 위한 Remdesivir: 무작위 대조 시험

Randomized Controlled Trial

Published on 2022-02-222022-09-11
Journal: CMAJ : Canadian Medical Association journal = jour [Category] COVID19(2023년), SARS, 임상, 치료제,

[키워드] 95% CI 95% confidence interval adverse event age Analysis assigned baseline Canada changes in Characteristics clinical outcomes Clinical severity conjunction Consent Controlled trial COVID-19 creatinine Data collection defined demographics dialysis duration of symptom Effect enrolment evaluated event followed by groups Health care health care systems Health Organization health systems hepatic dysfunction hospital Hospital mortality Hospital stay hospitals in-hospital mortality incidence intravenously mechanical ventilation mechanically ventilated Mortality no difference Open-label outcome oxygen Patient patients performed Pragmatic Primary outcome Randomized Randomized controlled trial randomized patient RCT receive receiving Relative risk Remdesivir risk secondary Secondary outcomes severity of symptom Sex significant effect solidarity Solidarity trial standard care Standard deviation Standard of care Standard-of-care Treatment Trial Trial registration ventilator-free day Ventilator-free days with COVID-19 World Health Organization
[DOI] 10.1503/cmaj.211698 PMC 바로가기 [Article Type] Randomized Controlled Trial

Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems

Commentary

Published on 2022-02-222022-11-01
Journal: Epidemiology and Infection [Category] COVID-19, COVID19(2023년), MERS, SARS,

Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine

초기 CovID-19 Pandemic 동안 입원 환자를위한 용도로 된 약물에 대한 치료 지침에 대한 임상 증거 : 코르티코 스테로이드, 항응고제, (Hydroxy) 클로로퀸

Review

Published on 2022-02-182022-08-31
Journal: Frontiers in Public Health [Category] COVID19(2023년), meta-analysis, SARS, 임상,

[키워드] adoption Analysis Anticoagulants best Chloroquine clinical Clinical data clinical evidence Clinical studies clinical study clinical trials Coagulopathy competing conducted coronavirus disease Coronavirus disease 2019 Corticosteroids COVID-19 drug Efficacy and safety evaluated Evidence evidence generation Factor Factors Germany guideline Health Organization hospital hospitalized COVID-19 patient hospitalized COVID-19 patients hydroxy identify incorporation Inflammation Informing International meta-analyses Meta-analysis MOST National national treatment observational studies pandemic Patient care platform Platform trial platform trials protocol provided question randomized clinical trial RCT RCTs recommendations referred to Repurposed drug Repurposed drugs researcher Result retrospective cohort retrospective cohort study robust scientific rigor severely ill patient severely ill patients Spread Treatment treatment guideline treatment guidelines trials United State United States Viral viral replication WHO World Health Organization
[DOI] 10.3389/fpubh.2022.804404 PMC 바로가기 [Article Type] Review